Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,577 | 131,337 | 269,712 | 113,432 | 82,956 |
| Marketable Securities | 404,481 | 486,949 | 445,604 | 346,274 | 420,142 |
| Receivables | 23,121 | 20,901 | 15,628 | 12,740 | 9,155 |
| Inventories | 14,138 | 13,632 | 10,948 | 7,065 | 5,556 |
| TOTAL | $613,486 | $699,431 | $786,887 | $522,369 | $567,480 |
| Non-Current Assets | |||||
| PPE Net | 31,877 | 25,317 | 21,696 | 20,046 | 19,828 |
| Investments And Advances | 26,333 | 24,167 | 0 | 0 | 0 |
| Intangibles | 173,426 | 173,475 | 173,492 | 173,629 | 174,638 |
| Other Non-Current Assets | 34,822 | 36,537 | 25,684 | 3,514 | 3,199 |
| TOTAL | $266,458 | $259,496 | $220,872 | $197,189 | $197,665 |
| Total Assets | $879,944 | $958,927 | $1,007,759 | $719,558 | $765,145 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,460 | 8,743 | 12,664 | 12,275 | 8,198 |
| Accrued Expenses | 69,557 | 59,264 | 48,957 | 62,450 | 58,483 |
| TOTAL | $90,307 | $75,006 | $66,880 | $74,725 | $66,681 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 31,206 | 32,968 | 22,984 | 4,759 | 4,702 |
| TOTAL | $62,372 | $64,134 | $54,150 | $35,925 | $35,868 |
| Total Liabilities | $152,679 | $139,140 | $121,030 | $110,650 | $102,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,771 | 57,692 | 57,472 | 51,279 | 50,580 |
| Common Shares | 58 | 58 | 57 | 51 | 51 |
| Retained earnings | -1,339,205 | -1,226,211 | -1,127,039 | -1,030,283 | -942,457 |
| Other shareholders' equity | -71 | 255 | -148 | -633 | -410 |
| TOTAL | $727,265 | $819,787 | $886,729 | $608,908 | $662,596 |
| Total Liabilities And Equity | $879,944 | $958,927 | $1,007,759 | $719,558 | $765,145 |